Persistence of biological agents over an eight-year period in rheumatoid arthritis and spondyloarthritis patients [PDF]
Farmacia Hospitalaria, 2019 Objective: To calculate the persistence, over a period of eight years, the retention rate of first and second-line of treatment with biological agents in patients with rheumatoid arthritis, spondyloarthritis and psoriatic arthritis and to compare ...
María Ángeles González-Fernández +5 more
doaj +5 more sources
Ustekinumab for the treatment of psoriatic arthritis: an update [PDF]
Clinical, Cosmetic and Investigational Dermatology, 2014 Parastoo Davari, Michael S Leo, Faranak Kamangar, Nasim Fazel Department of Dermatology, University of California, Davis, CA, USA Abstract: Psoriatic arthritis occurs in 30% of psoriasis patients, and the treatment can be challenging in some patients ...
Davari P, Leo MS, Kamangar F, Fazel N
doaj +3 more sources
Periods till psoriatic arthritis onset and diagnosis in Russian patients with moderate to severe psoriasis (according to psoriasis patient registry) [PDF]
Vestnik Dermatologii i Venerologii, 2023 Background. Early detection of psoriatic arthritis in patients with psoriasis remains an unmet medical need. Early diagnosis and treatment initiation in patients with psoriatic arthritis decreases the risk of adverse patient outcomes and improves ...
Alexey A. Kubanov, Elena V. Bogdanova
doaj +1 more source
The prevalence incidence of psoriatic onychodystrophy and the significance of its symptoms for the diagnosis of psoriatic arthritis [PDF]
Vestnik Dermatologii i Venerologii, 2021 Background. There is a need to assess the diagnostic significance of the symptoms of nail damage, as well as available effective methods for diagnosing psoriatic arthritis in the early stages. Aims.
Anna V. Platonova +6 more
doaj +1 more source
The age at first cutaneous manifestation of psoriasis as a prognostic factor in the timing of psoriatic arthritis diagnosis [PDF]
Vestnik Dermatologii i Venerologii, 2022 Background. Psoriatic arthritis is a chronic inflammatory disease of joints, spine and enthesis, which develops in 640% of patients with psoriasis and has a significant impact on the quality of life of patients. Aims.
Elena V. Bogdanova
doaj +1 more source
Results of one-year treat-to-target strategy in early psoriatic arthritis: data of an open-label REMARCA study [PDF]
Терапевтический архив, 2018 Objectives: to study efficacy of treat-to-target (T2T) strategy in early peripheral psoriatic arthritis (EPsA) after one year of treatment. Methods: 44 (M/F - 18/26) DMARD-naїve patients (pts) with active EPsA, according to the CASPAR criteria, mean age ...
T V Korotaeva +3 more
doaj +1 more source
Search for predictors of psoriatic arthritis in patients with psoriasis [PDF]
Vestnik Dermatologii i Venerologii, 2023 Background. Psoriatic arthritis is a chronic inflammatory disease of the joints, spine and entheses that can occur in patients with psoriasis. The prevalence of psoriatic arthritis is 19.7%.
Olga G. Artamonova +4 more
doaj +1 more source
BMJ Open, 2022 Introduction Psoriatic arthritis (PsA) is a complex, immune-mediated disease associated with skin psoriasis that, if left untreated, can lead to joint destruction. Up to 30% of patients with psoriasis progress to PsA.
Joseph F Merola +23 more
doaj +1 more source
The Association of Psoriatic Arthritis with Carotid Intima-Media Thickness [PDF]
Journal of Kerman University of Medical Sciences, 2021 Background: Previous studies have showed that psoriatic arthritis increases the risk of cardiovascular disease and atherosclerosis. On the other hand, an increased carotid intima-media thickness can be associated with atherosclerosis.
Hamidreza Talari +4 more
doaj +1 more source
Acta Dermato-Venereologica, 2022 Patients with psoriasis are at risk of developing psoriatic arthritis, which can lead to irreversible joint damage. However, a proportion of patients with psoriasis and concomitant psoriatic arthritis remain undiscovered in practice.
Tamara W. van Hal +6 more
doaj +1 more source